Alli Capsule
NDC Package 71610-805-34

11-digit billing NDC: 71610080534 · Billing unit: EA · 2280 EA per package

Package Information

Alli (orlistat) capsules is read the enclosed brochure for other important informationdiet and exercise are the starting points for any weight loss program. This formulation utilizes a capsule delivery system. Marketed by Aphena Pharma Solutions - Tennessee, Llc, this product is identified by NDC 71610-805 and is authorized under FDA application NDA021887.

Identification & Billing

NDC Package Code
71610-805-34
Package Description
2280 CAPSULE in 1 BOTTLE
Product Code
11-Digit Billing Format
71610080534
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
2280 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Alli
Non-Proprietary Name
Orlistat
Substance Name
Orlistat
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Read the enclosed brochure for other important informationdiet and exercise are the starting points for any weight loss program. Try these first before adding orlistat. Check with your doctor before starting any exercise program.to see if orlistat capsules are right for you, find your height on the chart to the right. You may consider starting a weight loss program with orlistat if your weight is the same or more than the weight shown for your height.for overweight adults 18 years and older:take 1 capsule with each meal containing fatdo not take more than 3 capsules dailyuse with a reduced-calorie, low-fat diet and exercise program until you reach your weight loss goal. Most weight loss occurs in the first 6 months.if you stop taking orlistat, continue with your diet and exercise programif you start to regain weight after you stop taking orlistat, you may need to start taking orlistat again along with your diet and exercise programtake a multivitamin once a day, at bedtime, when using orlistatHt. / Wt.4’10”129 lbs.4’11”133 lbs.5’0”138 lbs.5’1”143 lbs.5’2”147 lbs.5’3”152 lbs.5’4”157 lbs.5’5”162 lbs.5’6”167 lbs.5’7”172 lbs.5’8”177 lbs.5’9”182 lbs.5’10”188 lbs.5’11”193 lbs.6’0”199 lbs.6’1”204 lbs.6’2”210 lbs.6’3”216 lbs.6’4”221 lbs.6’5”227 lbs.

Regulatory & Marketing

Labeler Name
Aphena Pharma Solutions - Tennessee, Llc
Product Type
Human Otc Drug
FDA Application #
NDA021887
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-07-2007
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71610-805-34 identifies a specific commercial package of 2280 capsule in 1 bottle of Alli, a human over the counter drug labeled by Aphena Pharma Solutions - Tennessee, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 2280 billable units per package. This capsule is formulated for oral use and contains orlistat as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aphena Pharma Solutions - Tennessee, Llc on February 07, 2007. The current certification is valid through December 31, 2026.

How is this Aphena Pharma Solutions - Tennessee, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71610080534. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2280 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71610-805-34
11-Digit CMS (5-4-2)
71610-0805-34

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.